Genome‐wide association study identifies new susceptibility loci for cutaneous lupus erythematosus
暂无分享,去创建一个
J. Kere | I. König | A. Ziegler | W. Lieb | S. Blankenberg | J. Landsberg | H. Grallert | M. Müller-Nurasyid | A. Franke | J. Wenzel | T. Zeller | A. Schillert | J. Kruppa | M. Kunz | A. Kuhn | T. Tüting | A. Ranki | E. Schmidt | R. Gläser | N. Patsinakidis | Ann-Charlotte Rönn | T. Hasan | J. Panelius | J. Simon | S. Koskenmies | S. Ibrahim | Jochen Kruppa
[1] M. Haust,et al. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus , 2010, The British journal of dermatology.
[2] Liangdan Sun,et al. TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population , 2010, Lupus.
[3] Wentian Li,et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. , 2007, The New England journal of medicine.
[4] A. Kuhn,et al. The classification and diagnosis of cutaneous lupus erythematosus. , 2014, Journal of autoimmunity.
[5] J. McGregor,et al. Molecular genetics of cutaneous lupus erythematosus , 2001, Clinical and experimental dermatology.
[6] J. Kere,et al. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus , 2010, Experimental dermatology.
[7] P. Gaffney,et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. , 2011, Arthritis and rheumatism.
[8] Peter K Gregersen,et al. Recent advances in the genetics of autoimmune disease. , 2009, Annual review of immunology.
[9] Phillip A Sharp,et al. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails. , 2012, Genes & development.
[10] V. Bini,et al. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. , 2005, Rheumatology.
[11] C. Langefeld,et al. Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. , 2010, Arthritis and rheumatism.
[12] Pardis C Sabeti,et al. Identification of Two Independent Risk Factors for Lupus within the MHC in United Kingdom Families , 2007, PLoS genetics.
[13] P. Onkamo,et al. LUPUS AROUND THE WORLD Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations , 2008 .
[14] N. Fu,et al. TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process. , 2009, Experimental cell research.
[15] Liangdan Sun,et al. Down-regulated expression of IKZF1 mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus , 2011, Rheumatology International.
[16] A. Syvänen,et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus , 2011, PLoS genetics.
[17] M. Kimura,et al. Structure of an archaeal homolog of the human protein complex Rpp21-Rpp29 that is a key core component for the assembly of active ribonuclease P. , 2008, Journal of Molecular Biology.
[18] A. Sinha,et al. Cutaneous lupus erythematosus: Understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies , 2006, Autoimmunity.
[19] Y. Ben-Asouli,et al. Eukaryotic RNase P: role of RNA and protein subunits of a primordial catalytic ribonucleoprotein in RNA-based catalysis. , 2003, Molecular cell.
[20] T. Horiuchi,et al. Role of the MICA polymorphism in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.
[21] C. Günther,et al. Aicardi–Goutières syndrome: a model disease for systemic autoimmunity , 2014, Clinical and experimental immunology.
[22] Geoffrey Hom,et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. , 2008, The New England journal of medicine.
[23] G. van Loo,et al. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. , 2009, Trends in immunology.
[24] J. Kere,et al. Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population. , 2012, Rheumatology.
[25] Hyung-Sik Kang,et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. , 2009, Arthritis and rheumatism.
[26] S. Dovat,et al. Ikaros and tumor suppression in acute lymphoblastic leukemia. , 2011, Critical reviews in oncogenesis.
[27] M. Bijl,et al. Pathogenesis of cutaneous lupus erythematosus , 2008, Lupus.
[28] T. Ruzicka,et al. Classification of Cutaneous Lupus Erythematosus , 2005 .
[29] T. Vyse,et al. The genetics of lupus: a functional perspective , 2012, Arthritis Research & Therapy.
[30] A. Kuhn,et al. Photosensitivity, Apoptosis, and Cytokines in the Pathogenesis of Lupus Erythematosus: a Critical Review , 2014, Clinical Reviews in Allergy & Immunology.
[31] J. Wenzel,et al. Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches , 2007, Experimental dermatology.
[32] C. Kallenberg,et al. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus. , 2011, Clinical immunology.
[33] J. Kere,et al. Polymorphisms of the ITGAM Gene Confer Higher Risk of Discoid Cutaneous Than of Systemic Lupus Erythematosus , 2010, PloS one.
[34] L. Kiemeney,et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. , 2011, The New England journal of medicine.
[35] R. Naumann,et al. Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity , 2012, The Journal of experimental medicine.
[36] Marta E Alarcón-Riquelme,et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.
[37] A. Davidson,et al. Taming lupus—a new understanding of pathogenesis is leading to clinical advances , 2012, Nature Medicine.
[38] S. Kornbluth,et al. The Trim39 ubiquitin ligase inhibits APC/CCdh1-mediated degradation of the Bax activator MOAP-1 , 2012, The Journal of Cell Biology.
[39] A. Rosen,et al. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.
[40] F. Toberer,et al. Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray , 2013, Experimental dermatology.
[41] A. Aderem,et al. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE , 2006, The Journal of Experimental Medicine.
[42] D. Wieczorek,et al. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. , 2010, Arthritis and rheumatism.
[43] D. Nemazee,et al. Deletion of IgG-Switched Autoreactive B Cells and Defects in Faslpr Lupus Mice , 2010, The Journal of Immunology.
[44] Annette Lee,et al. Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G , 2012, Annals of the rheumatic diseases.
[45] J. Kere,et al. Familial systemic lupus erythematosus in Finland. , 2001, The Journal of rheumatology.
[46] F. Takeuchi,et al. The genetic contribution of HLA‐DRB5*01:01 to systemic lupus erythematosus in Thailand , 2013, International journal of immunogenetics.
[47] P. Gaffney,et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. , 2012, American journal of human genetics.
[48] H. Inoko,et al. TRIM39 and RNF39 are associated with Behçet's disease independently of HLA-B∗51 and -A∗26. , 2010, Biochemical and Biophysical Research Communications - BBRC.
[49] D. Geraghty,et al. A second lineage of mammalian major histocompatibility complex class I genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[50] A. Bank,et al. Multiple hematopoietic defects and delayed globin switching in Ikaros null mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[51] M. Sticherling,et al. Clinical Manifestations of Cutaneous Lupus Erythematosus , 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[52] P. Gregersen,et al. Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. , 2012, American journal of human genetics.
[53] A. Krieg,et al. Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity , 2007, Immunological reviews.
[54] G. Tsujimoto,et al. Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[55] P. Novota,et al. HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population , 2011, Rheumatology International.
[56] David Altshuler,et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus , 2008, Nature Genetics.
[57] R. Maul,et al. Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response , 2012, Genes and Immunity.
[58] S. Lei,et al. Functional Relevance for Associations between Genetic Variants and Systemic Lupus Erythematosus , 2013, PloS one.
[59] P. Gaffney,et al. High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions , 2009, PLoS genetics.
[60] H. Inoko,et al. TRIM39R, but not TRIM39B, regulates type I interferon response. , 2013, Biochemical and biophysical research communications.
[61] Pui-Yan Kwok,et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus , 2008, Nature Genetics.
[62] J. Goust,et al. Systemic lupus erythematosus. , 1976, Immunology series.
[63] M. Hochberg,et al. The application of genetic epidemiology to systemic lupus erythematosus. , 1987, The Journal of rheumatology.
[64] W. J. Morginson. [Lupus erythematosus]. , 1960, Revista medica hondurena.
[65] Jeanine J. Houwing-Duistermaat,et al. Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers , 2013, PLoS genetics.